Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.53 |
| ▸ | BLM | P54132 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.53 |
| ▸ | THPO | P40225 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 6/20 | 0.48 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.48 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 4/20 | 0.48 |
| ▸ | CA1 | P00915 | 3/20 | 0.48 |
| ▸ | GNPAT | O15228 | 1/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.47 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6445997 | 1.00 | ALOX15 (0.53) | ALOX15BLMKDM4EMAPTTHRB | |
| SCHEMBL6026388 | 1.00 | ALOX15 (0.53) | ALOX15BLMKDM4EMAPTTHRB | |
| SCHEMBL287578 | 1.00 | ALOX15 (0.53) | ALOX15BLMKDM4EMAPTTHRB | |
| Hydrochloric Acid SCHEMBL28715898 | 0.98 | ALOX15 (0.52) | ALOX15BLMKDM4EMAPTTHRB | |
| SCHEMBL147914 | 0.98 | ALOX15 (0.52) | ALOX15BLMKDM4EMAPTTHRB | |
| SCHEMBL7048124 | 0.98 | ALOX15 (0.52) | ALOX15BLMKDM4EMAPTTHRB | |
| Hydrochloric Acid SCHEMBL28715899 | 0.98 | ALOX15 (0.52) | ALOX15BLMKDM4EMAPTTHRB | |
| SCHEMBL31436738 | 0.98 | ALOX15 (0.52) | ALOX15BLMKDM4EMAPTTHRB | |
| SCHEMBL147916 | 0.98 | ALOX15 (0.52) | ALOX15BLMKDM4EMAPTTHRB | |
| Methyl Alcohol SCHEMBL27983826 | 0.98 | ALOX15 (0.52) | ALOX15BLMKDM4EMAPTTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1663 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | claimed |
| WO-2026087109-A1 | PERSONAL CARE COMPOSITION BASED ON AN ACETYL AMINOACID COMPOUND AND A CYSTINE COMPOUND | UNILEVER IP HOLDINGS B.V. (NL) | 2026-04-30 | — | — | WO | claimed |
| US-20260060912-A1 | SKIN CARE PRODUCT WITH PROTEIN MATRIX | Eighth Day Labs, LLC (US) | 2026-03-05 | — | — | US | claimed |
| US-12496266-B2 | Skin care product with protein matrix | Eighth Day Labs, LLC (US) | 2025-12-16 | — | — | US | claimed |
| US-20250354185-A1 | BLUE PIGMENT AND BIOSYNTHESIS METHOD THEREOF | VERTEXYN BIOWORKS CO LTD (CN) | 2025-11-20 | — | — | US | claimed |
| US-20250258146-A1 | QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP | HUMAN METABOLOMICS INSTITUTE INC. (CN) | 2025-08-14 | — | — | US | claimed |
| US-20250152499-A1 | COMPOSITIONS AND METHODS FOR SUPPORTING SKIN BARRIER HOMEOSTASIS | Skinfix Inc. (CA) | 2025-05-15 | — | — | US | claimed |
| WO-2025072741-A1 | PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-03 | — | — | WO | claimed |
| WO-2025068209-A1 | USE OF A MARKER SET FOR DETERMINING THE RISK OF DEVELOPING CASTRATION-RESISTANT PROSTATE CANCER | NUMARES AG (DE) | 2025-04-03 | — | — | WO | claimed |
| WO-2025068210-A2 | USE OF A MARKER SET FOR DETERMINING THE AGGRESSIVENESS OF A PROSTATE TUMOR | NUMARES AG (DE) | 2025-04-03 | — | — | WO | claimed |
| WO-1999030680-A1 | α-AMIDES OF L-AMINO ACIDS AS FRAGRANCE PRECURSORS | THE GILLETTE COMPANY (US) | 1999-06-24 | — | — | WO | claimed |
| WO-1999013819-A2 | COMPOSITION AND METHOD FOR REDUCING STINGING IN SKIN | E-L MANAGEMENT CORP. (US) | 1999-03-25 | — | — | WO | claimed |
| EP-0815833-A2 | Malodour preventing agents | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 1998-01-07 | — | — | EP | claimed |
| CN-1166320-A | Composite of zinc containing compound and glutamines | XIA XIAOLIN (CN) | 1997-12-03 | — | — | CN | claimed |
| EP-0627410-B1 | N-ACYLGLUTAMINE DERIVATIVE | KYOWA HAKKO KOGYO KK (JP) | 1997-10-29 | — | — | EP | claimed |
| WO-1995026744-A1 | TUMOR NECROSIS FACTOR INHIBITORS | CENTOCOR, INC. (US) | 1995-10-12 | — | — | WO | claimed |
| CN-1094057-A | Aceglutamide zinc salt and preparation thereof and application | CHU LIANGCHAI (CN) | 1994-10-26 | — | — | CN | claimed |
| EP-0440058-B1 | Cosmetic composition | KYOWA HAKKO KOGYO KK (JP) | 1994-10-12 | — | — | EP | claimed |
| US-5112613-A | Enhanced moisture retention, skin care | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1992-05-12 | — | — | US | claimed |
| EP-0440058-A1 | Cosmetic composition | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1991-08-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260060912-A1 | SKIN CARE PRODUCT WITH PROTEIN MATRIX | CUTA, HGFAC, BHMT | ALOX15 2800/4885BLM 4671/4885KDM4E 3373/4885 |
| US-20250354185-A1 | BLUE PIGMENT AND BIOSYNTHESIS METHOD THEREOF | ASNS, GLUL, GALE | ALOX15 3830/4885BLM 3800/4885KDM4E 1526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.